Viewing Study NCT06588335


Ignite Creation Date: 2025-12-24 @ 10:35 PM
Ignite Modification Date: 2026-01-19 @ 5:17 AM
Study NCT ID: NCT06588335
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-09-19
First Post: 2024-09-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: BTLA Inhibitor (JS004) Combined with Toripalimab and Chemotherapy in the Perioperative Treatment of Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma
Sponsor: Henan Provincial People's Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module